World of Warcraft Patch 12.0.5 is now live, but players aren't happy with the state of the first post-launch Midnight content update.

A new method replicated the findings of a previous clinical trial of Tecfidera in people with relapsing-remitting MS, a study ...

A fast-track method of breeding disease-resistant ash trees has been developed by researchers leading efforts to conserve the ...

Last patient visits for both OCS-01 Phase 3 DIAMOND trials (total 800+ patients) are complete, with topline results expected in June 2026A ...

Introduction Reduced exercise performance is common in patients with repaired tetralogy of Fallot (rToF) and relates to ...

SA and Lesotho to launch Senqu Bridge as LHWP Phase II gains momentum South Africa and the Kingdom of Lesotho will next week officially unveil the completed Senqu Bridge, marking a major milestone in ...

In a complex therapeutic landscape, WuXi AppTec is simplifying the path from discovery to patient. Find out how.

Researchers have developed a new imaging technique that captures more information about ultrafast processes in the ...

A second Royal Commission of Inquiry into New Zealand’s experience and handling of the COVID pandemic released its substantial report today, running to several volumes and hundreds of pages. The ...

Paying invoices sounds simple enough. A vendor creates an invoice and sends a bill, your team approves it, and the money goes out. In practice, though, invoice payments are where a lot of finance ...

LONDON & NEW YORK--(BUSINESS WIRE)--Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to accelerating patient access to evidence-based innovation, announced that tomorrow it will ...

AstraZeneca is taking its oral GLP-1 drug into phase 3 on the back of a pair of midstage weight loss wins, despite remaining tight-lipped on how the candidate actually performed. The U.K.-based Big ...